|
Volumn 6, Issue 12, 1999, Pages 693-696
|
Homocysteine testing and cardiovascular disease risk
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 OXOBUTYRIC ACID;
5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);
ADENOSINE TRIPHOSPHATE;
ADENOSYLHOMOCYSTEINASE;
BETAINE;
CARBON DIOXIDE;
CHOLESTEROL;
COLLAGEN;
CYANOCOBALAMIN;
CYSTATHIONINE;
CYSTATHIONINE BETA SYNTHASE;
CYSTEINE;
DIMETHYLGLYCINE;
FIBRIN;
FOLIC ACID;
GLUTATHIONE;
HOMOCYSTEINE;
LIPOPROTEIN;
METHIONINE;
METHIONINE ADENOSYLTRANSFERASE;
METHIONINE SYNTHASE;
METHYLTRANSFERASE;
MONOCLONAL ANTIBODY;
PYRIDOXINE;
S ADENOSYLMETHIONINE;
SERINE;
SULFATE;
TAURINE;
UNINDEXED DRUG;
ARTERY THROMBOSIS;
ASSAY;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONCENTRATION (PARAMETERS);
DIET SUPPLEMENTATION;
DRUG EFFECT;
HOMOCYSTINURIA;
HUMAN;
HYPERHOMOCYSTEINEMIA;
IMMUNOASSAY;
LABORATORY TEST;
MORTALITY;
REVIEW;
RISK FACTOR;
THROMBOCYTE AGGREGATION;
TISSUE INJURY;
|
EID: 0033402035
PISSN: 09696113
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (13)
|